Skip to main content
TipRanks
Go Ultimate75% OFF

Kuros Biosciences (CSBTF) Q4 2023 Earnings Report

15 Followers

CSBTF Q4 2023 EPS Results

Actual EPS
-$0.29
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$0.38

CSBTF Q4 2023 Revenue Results

Actual Revenue
$25.01M
Expected Revenue
$21.46M
Beat/Miss
Beat by +$3.56M
YoY Revenue Growth
+173.78%

Earnings Announcement Details

Quarter
Q4 2023
Date
03/13/2024
Time
Before Open
Conference Call
Wednesday, March 13, 2024
CSBTF Upcoming Earnings

Kuros Biosciences's next earnings date is estimated for March 3, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2023 Earnings Slide Deck

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

CSBTF Earnings History

CSBTF earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 03, 20272026 (Q4)0.10-0.11――
Aug 13, 20262026 (Q2)0.070.07-0.04262.22% (+0.12)
Mar 10, 20262025 (Q4)0.000.11-0.13184.55% (+0.25)
Aug 14, 20252025 (Q2)―-0.05-0.01-650.00% (-0.05)
Mar 11, 20252024 (Q4)―-0.13-0.2953.59% (+0.15)
Aug 08, 20242024 (Q2)―-0.01-0.1795.65% (+0.16)
Mar 13, 20242023 (Q4)―-0.29-0.3825.47% (+0.10)
Aug 09, 20232023 (Q2)―-0.17-0.14-22.12% (-0.03)
Mar 15, 20232022 (Q4)―-0.38-0.27-40.09% (-0.11)
Aug 09, 20222022 (Q2)―-0.140-3666.67% (-0.13)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed